Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches - Normandie Université Access content directly
Journal Articles Journal of Antimicrobial Chemotherapy Year : 2022
No file

Dates and versions

hal-03706317 , version 1 (27-06-2022)

Identifiers

Cite

Charlène Martin, Guillemette Unal, Jean-Christophe Plantier, Elodie Alessandri-Gradt. Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches. Journal of Antimicrobial Chemotherapy, 2022, ⟨10.1093/jac/dkac143⟩. ⟨hal-03706317⟩
21 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More